Skip to content
Archive

Kolinpharma® and RCS MediaGroup spa with Corriere Salute: together for a new culture of well-being

Kolinpharma® is pleased to announce the start of a new and prestigious editorial partnership with Corriere Salute, the weekly supplement of Corriere della Sera that has become a point of reference for medical and scientific information in Italy.

This partnership stems from a shared wish to give readers and patients clear, rigorous and certified information on the role of cutting-edge nutraceuticals. At a time when prevention and food supplements are taking a central role in everyday health, Kolinpharma® is sharing its scientific know-how and its patents to explore key topics in neurological, osteoarticular, uro-gynaecological and, from today, gastroenterological well-being.

Science and public information at the core

The project aims to close the gap between high-quality nutraceuticals and consumer awareness, through:

• Company presentation: Contributions on the clinical evidence supporting the efficacy of nutraceuticals.

• Focus on innovation: with the introduction of the new nutraceutical, PROINTEX®, which launches the specialist line dedicated to gastroenterologists

Kolinpharma's commitment

"Working with an authoritative publication like Corriere Salute is a key step for us on the path of transparency and public information that sets us apart," the company comments. "We are convinced that health starts, first of all, with correct information, based on scientific rigour and respect for the patient."

Follow our columns and special features in Corriere Salute to keep up to date with the latest news from Kolinpharma research.

Find out more

More news

  1. Kolinpharma® renews its partnership with La Neurologia Italiana: Research and Science at the Service of the Patient
  2. KOLINPHARMA® launched PROINTEX®, the innovative nutraceutical that marks the start of its new gastroenterology line
  3. KOLINPHARMA® lancia Kymax®
Archive